Japanese encephalitis and vaccines: Past and future prospects

Wiener Klinische Wochenschrift

Volumn 120, Issue SUPPL. 4, 2008, Pages 15-19

  Paulke Korinek, Maria ^a   Kollaritsch, Herwig ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Japanese encephalitis virus; Prophylaxis; Vaccination; Vaccine

Indexed keywords

'IC 50'; CHIMERIVAX JE; CHIMERIVAX JE VACCINE; IC 51 VACCINE; INACTIVATED VIRUS VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; PLACEBO; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANTIVIRAL THERAPY; CLINICAL TRIAL; DISEASE CARRIER; DRUG HYPERSENSITIVITY; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC ENCEPHALITIS; ERADICATION THERAPY; FEVER; HEADACHE; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; JAPANESE ENCEPHALITIS VIRUS; MOSQUITO; REVIEW; VACCINATION; VIRUS INFECTION;

ANTIBODIES, VIRAL; ASIA; CHILD; CROSS-SECTIONAL STUDIES; ENCEPHALITIS, JAPANESE; FORECASTING; HUMANS; JAPANESE ENCEPHALITIS VACCINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VACCINES, ATTENUATED; VACCINES, INACTIVATED; WEST NILE VIRUS VACCINES;

EID: 57849126033     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-008-1071-9     Document Type: Review

References (40)

1. Thiel H-J, Collett MS, Gould EA, Heinz FX, Houghton M, Meyers G, et al (2006) Index of viruses - flaviviridae in ICTVdB - The Universal Virus Database, version 4. Edition Büchen-Osmond C (ed). Columbia University, New York
2. T Solomon H Ni DWC Beasley M Ekkelenkamp MJ Cardosa ADT Barrett 2003 Origin and evolution of Japanese Encephalitis virus in southeast Asia J Virol 77 3091 3098
3. H Sumiyoshi C Mori I Fuke K Morita S Kuhara J Kondou 1987 Complete nucleotide sequence of the Japanese Encephalitis virus genome RNA Virology 161 497 510
4. A Oya I Kurane 2007 Japanese Encephalitis for a reference to international travelers J Travel Med 14 259 268
5. E Konishi M Yamaoka W Khin Sane I Kurane K Takada PW Mason 1999 The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese Encephalitis virus premembrane and envelope genes J Virol 73 5527 5534
6. Halstead SB, Jacobsen J (2008) Japanese Encephalitis vaccines. In: Plotkin SA, Orenstein WA, Offit P (eds) Vaccines, Edition 4. Saunders Elsevier, pp 311-352
7. Centers for Disease Control and Prevention 1993 Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 42 1 15
8. DJ Gould RJ Byrne DE Hayes 1964 Experimental infection of horses with Japanese Encephalitis virus by mosquito bite Am J Trop Med Hyg 13 742 746
9. IP Sunish R Reuben 2001 Factors influencing the abundance of Japanese encephalitis vectors in rice fields in India - I. Abiotic Med Vet Entomol 15 381 392
10. WHO 2006 Japanese Encephalitis vaccines: WHO position paper Weekly Epidemiological Record 81 331 340
11. WHO www.who.int/vaccine_research/diseases/vector/en/index1.html (download on: 9. 7. 2008)
12. TF Tsai 2000 New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998 Vaccine 18 1 25
13. J Hanna S Ritchie D Phillips J Lee S Hills A van den Hurk 1999 Japanese encephalitis in north Queensland, Australia, 1998 Med J Aust 170 533 536
14. WHO - SEARO (2005) www.searo.who.int/en/section1226/section2073.asp (download on: 9.7. 2008)
15. WHO (2005) www.wpro.who.int/NR/rdonlyres/A62D4A75-0C28-4093-95CF- 555CE379C469/0/MTGRPT_BiregionalJE2005.pdf (download on: 10. 7. 2008)
16. A Gajanana V Thenmozhi PP Samuel R Reuben 1995 A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese Encephalitis is endemic Bull World Health Organ 73 237 244
17. MC Steinhoff 1996 Japanese Encephalitis: a Chinese solution? Lancet 347 1570 1571
18. EA Gould T Solomon 2008 Pathogenic flaviviruses The Lancet 371 500 509
19. T Solomon NM Dung B Wills R Kneen M Gainsborough TV Diet 2003 Interferon alfa-2a in Japanese Encephalitis: a randomised double-blind placebo-controlled trial The Lancet 361 821 826
20. T Solomon 2006 Control of Japanese Encephalitis - within our grasp? N Engl J Med 355 869 871
21. E Tauber H Kollaritsch M Korinek P Rendi-Wagner B Jilma C Firbas 2007 Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese Encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial The Lancet 370 1847 1853
22. A Oya 1988 Japanese Encephalitis vaccine Acta Paediatr Jpn 30 175 184
23. Schioler KL, Samuel M, Wai KL (2007) Vaccines for preventing Japanese Encephalitis (Review). Cochrane Database Syst Rev 1-44
24. T Jelinek 2008 Japanese Encephalitis vaccine in travelers Expert Rev Vaccines 7 689 693
25. K Sugawara K Nishiyama Y Ishikawa M Abe K Sonoda K Komatsu 2002 Development of vero cell-derived inactivated Japanese Encephalitis vaccine Biologicals 30 303 314
26. M Sakaguchi H Miyazawa S Inouye 2001 Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese Encephalitis vaccines Allergy 56 536 539
27. Kollaritsch H (2000) Japan-B-Encephalitis. In: Kollaritsch H, Wiedermann G (eds) Leitfaden für Schutzimpfungen. Springer, Wien New York, pp 240-246
28. WHO 2005 Global Advisory Committee on Vaccine Safety, 9-10 June 2005 Weekly Epidemiological Record 28 242 243
29. Yaïch M, Jacobson J (2007) whqlibdoc.who.int/hq/2007/WHO_IVB_07. 10_eng.pdf (download on: 11.7. 2008)
30. T Solomon 2008 New vaccines for Japanese Encephalitis Lancet Neurol 7 116 118
31. WHO 1998 WHO Requirements for the use of animal cells and in vitro substrates for the production of biologicals (Requirements for Biological Substances No 50) Biologicals 26 175 193
32. GAVI Applied Strategies (June 2008) www.gavialliance.org/resources/ 18_JE_Landscape_Jun08.pdf (download on: 9.7.2008)
33. A Lyons N Kanesa-thasan RA Kuschner KH Eckels R Putnak W Sun 2007 A phase 2 study of a purified, inactivated virus vaccine to prevent Japanese Encephalitis Vaccine 25 3445 3453
34. Intercell www.intercell.co.at/SelectMenu.wa?seIDM=7FEF900D-F23A-47E1- 8DEA-30E27BA97242 (download on: 10.7.2008)
35. Presseportal (2006) www.presseportal.de (download on: 15.2.2008)
36. Acambis www.acambis.co.uk/default.asp?id=1917 (download on: 15.2.2008)
37. T Monath F Guirakhoo R Nichols S Yoksan R Schrader C Murphy 2003 Chimeric live, attenuated vaccine against Japanese Encephalitis (ChimeriVax™-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese Encephalitis antigen J Infect Dis 188 1213 1230
38. TP Monath K McCarthy P Bedford CT Johnson R Nichols S Yoksan 2002 Clinical proof of principle for ChimeriVax™-JE: Recombinant live, attenuated vaccines against flavivirus infections Vaccine 20 1004 1018
39. Clinicaltrials.gov www.clinicaltrials.gov/ct2/show/NCT00621764?term= chimerivax-je&rank=2 (download on: 10.7. 2008)
40. M Reid D Mackenzie A Baron N Lehmann KYM Lowry J Aaskov 2006 Experimental infection of culex annulirostris, cluex gelidus, and aedes vigilax with a yellow fever/Japanese Encephalitis vaccine chimera (ChimeriVax™-JE) Am J Trop Med Hyg 75 659 663